- Coordinator
- Technische Universitat Dortmund, Germany
- Runs
- 1 October 2026 to 31 March 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101335348
What the project is doing
In the project's own words, from its summary on CORDIS.
Over the last decades there has been a growing demand to leave the flat land of drug design and to access the three-dimensional (3D) space by embedding 3D scaffolds into drug molecules. 3D building blocks such as cubanes, bicyclo[2.2.2]octanes or bicyclo[1.1.1]pentanes have been well explored, are commercially available and are commonly found in the patent literature of pharmaceuticals and agrochemicals. Substituting phenyl groups by 3D building blocks (bioisosters) can increase pharmacokinetics such as aqueous solubility or improves metabolic stability.
SPIROPENT will establish novel building blocks based on the spiro[2.2]pentane core. Due to the intrinsic challenges associated with spiro[2.2]pentanes such as their complex stereochemistry, as well step-intense synthesis, such building blocks are so far not well explored, particularly as linker elements in pharmaceuticals. This proposal aims to embed the spiro[2.2]pentanes into an additional cycle yielding novel tricyclic, rigid, chiral and three-dimensional building blocks which will solve the typical problems associated with spiro[2.2]pentanes and represents a terra incognita for drug design.
We will establish a new synthetic access based on single C-atom transfer which we have recently pioneered. SPIROPENT will explore and scale up the synthesis of the new tricyclic building blocks as well as incorporate them into biological targets with the overarching aim of commercialization.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technische Universitat Dortmund | Dortmund | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI